. home.aspx



GE Healthcare partners with Vanderbilt University on precision immunotherapy apps

January 09, 2019 / Eli Richman

GE Healthcare and Vanderbilt Medical Center launched a partnership this week to deliver more precision in immunotherapy treatment. Over the next five years, the two organizations will conduct retrospective research on cancer patients' treatment to develop a picture of what treatment works for each individual. They will then use that data to create an AI-powered app which physicians can use to select the best type of treatment for each patient. “Immunotherapy offers tremendous promise but given the current unpredictability of some patients’ reactions to treatments, it is also associated with increased morbidity and cost. This partnership provides the opportunity to leverage strengths of both of our organizations to further personalize cancer care by creating new tools that allow clinicians to more accurately predict how patients will respond to a specific therapy,” said Jeff Balser, M.D., president and CEO of Vanderbilt University Medical Center and dean of the Van...